Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Merck Sharp & Dohme LLC
Shirish Gadgeel; Delvys Rodríguez-Abreu; Giovanna Speranza; Emilio Esteban; Enriqueta Felip; Manuel Dómine; Rina Hui; Maximilian J Hochmair; Philip Clingan; Steven F Powell; Susanna Yee-Shan Cheng; Helge G Bischoff; Nir Peled; Francesco Grossi; Ross R Jennens; Martin Reck; Edward B Garon; Silvia Novello; Belén Rubio-Viqueira; Michael Boyer; Takayasu Kurata; Jhanelle E Gray; Jing Yang; Tuba Bas; M Catherine Pietanza; Marina C Garassino